Chief Financial Officer

Chief Medical Officer

Hope for Rare Pediatric Disease Voucher Reignited as House Bill Passes Committee

Amylyx Pharmaceuticals announces pricing of $175 million underwritten public offering of common stock

Amylyx 17.5M share Spot Secondary priced at $10.00

Amylyx Pharmaceuticals Prices $175 Million Common Stock Offering

Director, Bioanalytical and Translational Science

Amylyx Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing novel therapies for high unmet needs. They are seeking an experienced scientist to lead bioanalytical strategy and operations, contributing to multiple drug programs and managing vendor relationships to support preclinical and clinical pipelines.

Senior Vice President, Human Resources and Talent Acquisition

Head of Talent & HR Business Partnering

Director, Quality Management Systems

Senior Director Clinical Quality Assurance

Sign up with Google

Sign in with Google